In the IgE >100 IU/ml group of lung cancer patients, the risk of developing lung cancer in subjects aged ≥65 years was 4.775-fold higher than those aged <65 years (OR = 4.775, 95% CI = 3.478–6.555; P <0.001). Here, IGHE is linked to lung cancer.